-
Product Insights
Appetite (Eating) Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Appetite (Eating) Disorders - Drugs In Development, 2023’, provides an overview of the Appetite (Eating) Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Appetite (Eating) Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Critical Limb Ischemia – Drugs In Development, 2023
Global Markets Direct’s, ‘Critical Limb Ischemia - Drugs In Development, 2023’, provides an overview of the Critical Limb Ischemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Critical Limb Ischemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Attention Deficit Hyperactivity Disorder (ADHD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Drugs In Development, 2023’, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Attention Deficit Hyperactivity Disorder (ADHD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Pruritus – Drugs In Development, 2023
Global Markets Direct’s, ‘Pruritus - Drugs In Development, 2023’, provides an overview of the Pruritus pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pruritus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Myocardial Infarction – Drugs In Development, 2023
Global Markets Direct’s, ‘Myocardial Infarction - Drugs In Development, 2023’, provides an overview of the Myocardial Infarction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myocardial Infarction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Hydromorphone Hydrochloride SR in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Hydromorphone Hydrochloride SR in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hydromorphone Hydrochloride SR in Pain Drug Details: Hydromorphone hydrochloride SR is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cantharidin in Genital Warts (Condylomata Acuminata)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cantharidin in Genital Warts (Condylomata Acuminata) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cantharidin in Genital Warts (Condylomata Acuminata) Drug Details: Cantharidin (Ycanth)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Idelalisib in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Idelalisib in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Idelalisib in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Drug Details:Idelalisib (Zydelig) drug belongs...
-
Product Insights
Hubei Sanning Chemical Yichang Complex, China
Hubei Sanning Chemical Yichang Complex is located in Hubei, China. It is operated by Hubei Sanning Chemical Co Ltd. Empower your strategies with our Hubei Sanning Chemical Yichang Complex, China report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data...
-
Sector Analysis
Peru Beer and Cider Market Overview by Category, Price Segment Dynamics, Brand and Flavour, Distribution and Packaging, 2023
Peru Beer and Cider Market Report Overview The Peru beer and cider market size was LCU11.5 billion in 2022. The market is expected to grow at a CAGR of more than 2% during 2023-2028. Peru Beer and Cider Market Outlook, 2022-2028 (LCU Billion) Buy Full Report for More Insights into the Peru Beer and Cider Market Forecast Download a Free Report Sample  The Peru beer and cider market research report provides detailed data analysis of the beer and cider sector...